About this visual
Joe’s original guide to eligibility, prescription routing, and prior authorization.
Sources & further reading
Original LinkedIn post and discussion ↗
Additional references appear in the infographic and the original LinkedIn discussion.




🚨 Medicare GLP-1 coverage for obesity begins July 1, 2026. Here is a straightforward provider guide to the new Medicare GLP-1 Bridge Program.
The Bridge provides certain Medicare Part D beneficiaries access to covered obesity medications for a flat $50 copay per 28- or 30-day fill, with no deductible.
WHO MAY QUALIFY?
The patient must:
• Be age 18 or older
• Have eligible Medicare Part D coverage
• Be prescribed treatment specifically for weight reduction and maintenance
• Participate in ongoing nutrition and physical activity intervention
• Not have already received a GLP-1 through their Part D plan
• Not be seeking coverage for another Part D-coverable indication, such as type 2 diabetes, moderate-to-severe obstructive sleep apnea, MASH, or cardiovascular risk reduction
The patient must also have met one of these criteria when GLP-1 therapy was originally started:
• BMI ≥35
• BMI ≥30 plus HFpEF, uncontrolled hypertension despite 2 medications, or CKD stage 3a+
• BMI ≥27 plus prediabetes, prior MI, prior stroke, or symptomatic peripheral artery disease
Important: Eligibility is based on BMI at treatment initiation, not necessarily the patient’s current BMI.
COVERED MEDICATIONS
• Wegovy injection or tablets
• Foundayo tablets
• Zepbound KwikPen
Zepbound single-dose pens and vials are not covered through the Bridge.
HOW TO SUBMIT
1. Confirm plan and clinical eligibility.
2. Send the prescription to the pharmacy with:
• An E66 obesity diagnosis code
• The exact note: “SEND TO BRIDGE FOR WEIGHT MANAGEMENT”
This is important. Without it, the pharmacy may route the claim to the patient’s regular Part D plan.
3. Wait for the pharmacy to send the prior authorization request, usually within 24 to 72 hours.
4. If no request arrives within 72 hours, download and submit the CMS Bridge fax form.
5. Complete the PA attestation carefully. CMS may verify diagnoses, prior coverage, and eligibility using Medicare data. The PA can be completed via CoverMyMeds.
6. Approval or denial should be returned within 72 hours.
After the first approved fill, another PA is generally not required unless the patient switches to a different covered GLP-1.
KEY DETAILS
• Program starts July 1, 2026
• Flat $50 patient copay
• No deductible
• Only 28- or 30-day fills
• A new PA is required when switching medications
• Prescribers do not need to be enrolled in Medicare, but cannot be on the CMS Preclusion List
Please share this with prescribers, pharmacists, nurses, medical assistants, and prior authorization teams. Correct routing will be critical to helping eligible Medicare patients access treatment.
UPDATE: Added FAQs in the comments section.